Hepatoblastoma Study. Strategy for High-Risk and Treatment-Refractory Hepatoblastoma
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
RNA sequencing for study samples. Patients with metastatic, treatment-refractory, and relapsed hepatoblastoma (HB) have survival rates of less than 50% due to limited treatment options. To develop new therapeutic strategies for these patients, our lab has developed a preclinical testing pipeline.
创建时间：
2023-11-21
